1. Home
  2. WDFC vs ARQT Comparison

WDFC vs ARQT Comparison

Compare WDFC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$226.70

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.98

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
ARQT
Founded
1953
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
WDFC
ARQT
Price
$226.70
$25.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$270.00
$34.00
AVG Volume (30 Days)
163.0K
1.3M
Earning Date
04-09-2026
05-06-2026
Dividend Yield
1.91%
N/A
EPS Growth
30.92
88.79
EPS
5.02
N/A
Revenue
$488,109,000.00
$376,072,000.00
Revenue This Year
$8.23
$34.85
Revenue Next Year
$5.85
$29.39
P/E Ratio
$45.28
N/A
Revenue Growth
19.49
91.34
52 Week Low
$175.38
$13.70
52 Week High
$298.90
$31.77

Technical Indicators

Market Signals
Indicator
WDFC
ARQT
Relative Strength Index (RSI) 45.15 44.02
Support Level $199.17 $24.96
Resistance Level $249.89 $27.26
Average True Range (ATR) 7.32 1.09
MACD -2.67 -0.29
Stochastic Oscillator 24.81 11.70

Price Performance

Historical Comparison
WDFC
ARQT

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: